Detalles de la búsqueda
1.
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.
Biol Blood Marrow Transplant;
25(7): 1293-1303, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30951840
2.
Long-term implications of autologous HCT for caregiver quality of life: how does the survivor's health matter?
Support Care Cancer;
27(1): 191-198, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29926161
3.
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
Biol Blood Marrow Transplant;
24(4): 700-707, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29289757
4.
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
23(3): 405-411, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28007665
5.
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network.
Biol Blood Marrow Transplant;
22(8): 1440-1448, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118571
6.
Exploring long-term cancer survivors' experiences in the career and financial domains: Interviews with hematopoietic stem cell transplantation recipients.
J Psychosoc Oncol;
34(1-2): 2-27, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26492184
7.
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
Biol Blood Marrow Transplant;
21(1): 4-7, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25278457
8.
Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era.
Biol Blood Marrow Transplant;
21(1): 142-50, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445638
9.
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant;
21(6): 971-83, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773017
10.
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Biol Blood Marrow Transplant;
21(9): 1605-11, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983043
11.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Biol Blood Marrow Transplant;
21(12): 2091-2099, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26253007
12.
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Cancer;
121(20): 3709-16, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26207349
13.
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.
Blood;
122(24): 3871-8, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081656
14.
Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms.
Biol Blood Marrow Transplant;
20(6): 837-43, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24607552
15.
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.
Blood;
119(25): 6145-54, 2012 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22563089
16.
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
Blood;
120(20): 4256-62, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23007405
17.
Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.
Biol Blood Marrow Transplant;
19(12): 1740-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24096096
18.
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.
Biol Blood Marrow Transplant;
19(5): 746-53, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23380340
19.
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
Br J Haematol;
162(5): 648-56, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23829536
20.
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.
Biol Blood Marrow Transplant;
18(7): 1036-1043.e1, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22155506